fastandbulbous
Bluelight Crew
AfterGlow said:I think pharma would try to avoid developing new drugs that have a high potential for abuse. So maybe the best drugs are already here??
MDMA, 2C-B, salvinorin A etc aren't the product of pharmaceutical lcompanies (unless you count the original synthesis of MDMA by E Merck in 1912!), but of researchers investigating either structural activity relationships or receptor binding studies. That's the source of a lot of inspiration for modifications or completely novel drugs, and among those there must be some that surpass the original starting inspiration eg starting from either methylphenidate or cathinone there's a direct development line to MDPV, something that was unknown half a decade ago.
I somehow doubt that we've seen the best there is to see w.r.t. just about every class of drug covered here